PE/VC Fundraising - Acquisitions & Exits - Funding Rounds - Tell us about your Deals - Sign up for Newsletter

Novo A/S

Orphazyme ApS Complete EUR 14M Financing Round

NeRRe Therapeutics Raises £23 million in an oversubscribed Series B financing round.

Hoba Therapeutics launches with $2 million in seed financing

Acesion Pharma raises €9.1 million in first closing of new funding from Novo Seeds and Wellcome Trust.

Inthera Bioscience, Swiss biopharma company, raises €3.4M funding round led by MS Ventures, Aglaia & Novo Seeds

Merus, a Netherlands-based biotech company, gains a €72.8M funding through a Series C round led by Sofinnova and Novo A/S

KalVista Pharmaceuticals, a research-led pharmaceutical company, raises $33M in a Series B funding

Gilead Sciences acquires EpiTherapeutics, a developer of innovative cancer drugs, for $65M

Orphazyme, a pharma company, raises €20M in a Series B financing round